Capital Advisors Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.37M Buy
1,180
+98
+9% +$116K 0.15% 83
2026
Q2
$1.3M Buy
1,082
+561
+108% +$573K 0.15% 84
2026
Q1
$479K Sell
521
-11
-2% -$11.2K 0.06% 132
2025
Q4
$571K Buy
532
+39
+8% +$37.3K 0.08% 120
2025
Q3
$377K Sell
493
-19
-4% -$14.1K 0.05% 142
2025
Q2
$399K Buy
512
+93
+22% +$72.3K 0.06% 132
2025
Q1
$346K Buy
419
+28
+7% +$23.3K 0.06% 128
2024
Q4
$302K Sell
391
-22
-5% -$18.2K 0.05% 132
2024
Q3
$366K Buy
413
+13
+3% +$11.7K 0.07% 113
2024
Q2
$362K Hold
400
– – 0.07% 107
2024
Q1
$311K Hold
400
– – 0.06% 113
2023
Q4
$233K Sell
400
-8
-2% -$4.67K 0.05% 130
2023
Q3
$219K Buy
+408
New +$210K 0.06% 123

Other funds holding LLY

Capital Advisors Wealth Management's LLY Position: Q3 2026 in Review

Capital Advisors Wealth Management increased its Eli Lilly (LLY) stake by 9.1% in Q3 2026, buying an estimated $116K and bringing the position to 1,180 shares worth $1.37M. The position accounts for 0.15% of the portfolio, ranked #83.

Capital Advisors Wealth Management first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Capital Advisors Wealth Management held 1,180 shares of Eli Lilly worth $1.37M as of Q3 2026.
  • Capital Advisors Wealth Management bought 98 Eli Lilly shares in Q3 2026, an estimated $116K.
  • Eli Lilly made up 0.15% of Capital Advisors Wealth Management's portfolio in Q3 2026, its #83 holding.
  • Capital Advisors Wealth Management first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capital Advisors Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.